INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q3 2017. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,025,000 | +1863.4% | 125,190 | +1657.8% | 0.25% | +1838.5% |
| Q3 2018 | $205,000 | -23.2% | 7,122 | 0.0% | 0.01% | -23.5% |
| Q2 2018 | $267,000 | -4.6% | 7,122 | 0.0% | 0.02% | -15.0% |
| Q1 2018 | $280,000 | +21.2% | 7,122 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $231,000 | +4.1% | 7,122 | 0.0% | 0.02% | -5.9% |
| Q3 2017 | $222,000 | +8.8% | 7,122 | 0.0% | 0.02% | +142.9% |
| Q2 2015 | $204,000 | – | 7,122 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |